A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Oligometastatic Breast Carcinoma · Breast Cancer · Metastatic Breast Cancer · Metastatic Breast Carcinoma · ER+ Breast Cancer · HER2+ Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Amy Xu, MD, PhD) · 646-888-6863
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Amy Xu, MD, PhD) · 646-888-6863
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Amy Xu, MD, PhD) · 646-888-6863
  • Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Amy Xu, MD, PhD) · 646-888-6863
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Amy Xu, MD, PhD) · 646-888-6863
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Amy Xu, MD, PhD) · 646-888-6863
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Amy Xu, MD, PhD) · 646-888-6863
  • Lehigh Valley Health Network (Data Collection Only), Allentown, Pennsylvania, United States

    Contact: Study coordinator (Alyson McIntosh, MD) · 610-402-0700
Study leads
  • Amy Xu, MD, PhD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center